MGT Ships 15 Advanced Sterilization Systems to Central Asia, Boosting Regional Healthcare Infrastructure

MGT Technologies, a global leader in medical sterilization solutions, today successfully dispatched fifteen (15) industrial-grade autoclave systems from its manufacturing facility, marking its strategic entry into the Central Asian market. 

Strategic Expansion This milestone represents MGT’s first major export initiative to Central Asia following the recent signing of distribution agreements with Almaty-based MedSupply LLP and Tashkent MedGroup.

The GT-Series sterilizers feature:

• WHO-compliant Class B certification
• Dual-functionality for medical instruments & laboratory equipment
• 30% faster cycle times than regional alternatives
• Multilingual touchscreen interfaces (Russian/Kazakh/Uzbek)

Logistical Execution The containerized units underwent rigorous pre-shipment testing at MGT’s ISO 13485-certified plant before being loaded onto temperature-controlled trucks. The shipment will clear customs at the Khorgos Eastern Gate Special Economic Zone before regional distribution.

Executive Insight "MGT’s sterilization technology meets the critical demand for infection control in Central Asia’s rapidly modernizing hospitals," stated David Chen, CEO of MGT. "These 15 systems will serve over 2 million patients annually across 7 regional hospitals – a testament to our commitment to global health equity."

Market Context The Central Asian medical equipment market is projected to grow at 11.3% CAGR through 2028 (GlobalData). MGT’s expansion aligns with Kazakhstan’s 2025 Healthcare Modernization Initiative and Uzbekistan’s Presidential Decree PP-4887 on medical infrastructure upgrades.

Visual Assets Available:

• High-res images of loading operation
• Technical specifications sheet
• Regional healthcare impact infograpHic

Next Phase: MGT will deploy technical teams in Q3 for installation supervision and staff training programs accredited by the European Association of Central Sterile Supply Departments (EACSSD).